CSI Market
Sign In | Register

Corbus Pharmaceuticals Holdings Inc (CRBP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CRBP Annual Balance Sheets →
Quarterly balance sheet trends provide context on Corbus Pharmaceuticals Holdings Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CRBP/balance-sheets
https://api.csimarket.com/api/v1/companies/CRBP/fundamentals
https://api.csimarket.com/api/v1/companies/CRBP/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent30.25
Restricted Cash0.39
Short-term Investments, Total85.09
Cash & Short-term Investments115.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.61
Total Current Assets118.95
Equipment/Property/Plant Net4.49
Deferred, Prepaid and Other Assets, Noncurrent3.61
Other Assets, Noncurrent0.00
Restricted Cash Current0.39
Restricted Cash Noncurrent-
Operating Lease Right Of Use Asset0.80
Total Assets122.90
Liabilities
Accounts Payable, Current AC4.07
Accrued Liabilities, Current AC30.17
Other Liabilities, Current0.73
Total Current Liabilities34.97
Total Long-term Debt0.00
Other liabilities, Noncurrent3.18
OperatingLeaseLiabilityNoncurrent-
Operating Lease Liability Current1.21
Total Liabilities38.14
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock736.14
Retained Earnings / Accumulated Deficit-651.19
Accumulated Other Comprehensive Income-0.20
Other Equity-0.20
Common Stockholder's Equity84.76
Total Stockholder's Equity84.76
Liabilities & Stockholder's Equity122.90
4 historic quarters locked

Sign in to unlock the full Corbus Pharmaceuticals Holdings Inc balance sheet history.

Sign In Create Free Account

About Corbus Pharmaceuticals Holdings Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260930)
  • Filed with the SEC: November 10, 2026
  • Source: crbp-20260930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-455614

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI